Matthew Winton

Insider Reports History

Location
Boston, MA
Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Winton:

Company Role Class Num Shares Value Price $ Report Date Ownership
Inozyme Pharma, Inc. COO Restricted Stock Units 0 $184,675 $4.45 01 Jul 2025 Direct
CervoMed Inc. Chief Commercial and Business Common Stock 15,000 $119,250 $7.95 18 Nov 2025 Direct
Inozyme Pharma, Inc. COO Common Stock 0 $0 $4.00 01 Jul 2025 Direct
CervoMed Inc. Chief Commercial and Business Stock Option (Right to Buy) 75,000 06 Oct 2025 Direct
Inozyme Pharma, Inc. COO Stock Option (Right to Buy) 0 01 Jul 2025 Direct

Insider Reports Filed by Matthew Winton

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRVO CervoMed Inc. 17 Nov 2025 2 +$41,430 4 Chief Commercial and Business 19 Nov 2025, 07:46
CRVO CervoMed Inc. 14 Nov 2025 1 +$75,700 4 Chief Commercial and Business 17 Nov 2025, 09:01
CRVO CervoMed Inc. 06 Oct 2025 1 $0 4 Chief Commercial and Business 08 Oct 2025, 16:07
CRVO CervoMed Inc. 06 Oct 2025 0 $0 3 Chief Commercial and Business 08 Oct 2025, 16:06
INZY Inozyme Pharma, Inc. 01 Jul 2025 3 -$86,972 4 COO 03 Jul 2025, 19:08
INZY Inozyme Pharma, Inc. 25 Jun 2025 1 +$10,623 4 COO 27 Jun 2025, 16:05
INZY Inozyme Pharma, Inc. 31 Mar 2025 1 +$1,917 4 COO 02 Apr 2025, 16:29
INZY Inozyme Pharma, Inc. 11 Mar 2025 2 $0 4 COO 17 Mar 2025, 16:25
INZY Inozyme Pharma, Inc. 30 Sep 2024 1 +$7,610 4 COO 03 Oct 2024, 20:57
INZY Inozyme Pharma, Inc. 28 Mar 2024 1 +$10,616 4 COO 03 Apr 2024, 17:23
INZY Inozyme Pharma, Inc. 13 Mar 2024 1 $0 4 COO 15 Mar 2024, 08:30
INZY Inozyme Pharma, Inc. 03 Apr 2023 1 $0 4 COO 04 Apr 2023, 08:35
INZY Inozyme Pharma, Inc. 03 Apr 2023 0 $0 3 COO 04 Apr 2023, 08:31